https://stock.noler.com/us/stock/durata-therapeutics-inc https://stock.noler.com/us/stock/durata-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/durata-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-employee-benefits-current-and-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/durata-therapeutics-inc/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-assets-arising-from-contingencies-amount-recognized https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-contingent-consideration-asset https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/durata-therapeutics-inc/acquisition-costs https://stock.noler.com/us/stock/durata-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/durata-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/durata-therapeutics-inc/amortization https://stock.noler.com/us/stock/durata-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/durata-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/durata-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/durata-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/durata-therapeutics-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-contingent-consideration-at-fair-value https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-contingent-consideration-at-fair-value-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-purchase-price-allocation-deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/durata-therapeutics-inc/business-acquisition-purchase-price-allocation-intangible-assets-not-amortizable https://stock.noler.com/us/stock/durata-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/durata-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/durata-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/durata-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/durata-therapeutics-inc/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/durata-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/durata-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/durata-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/durata-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/durata-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/durata-therapeutics-inc/contracts-revenue https://stock.noler.com/us/stock/durata-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/durata-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/durata-therapeutics-inc/current-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/durata-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-interest-rate https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/durata-therapeutics-inc/debt-unused-borrowing-capacity-amount https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-finance-costs-gross https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-income-taxes-and-other-assets-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-liabilities-deferred-expense-capitalized-research-and-development-costs https://stock.noler.com/us/stock/durata-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/durata-therapeutics-inc/depreciation https://stock.noler.com/us/stock/durata-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/durata-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/durata-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/durata-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/durata-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/durata-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/durata-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/durata-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/durata-therapeutics-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/durata-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/durata-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/durata-therapeutics-inc/goodwill https://stock.noler.com/us/stock/durata-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/durata-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/durata-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/durata-therapeutics-inc/impairment-of-investments https://stock.noler.com/us/stock/durata-therapeutics-inc/income-tax https://stock.noler.com/us/stock/durata-therapeutics-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/durata-therapeutics-inc/income-tax-receivable https://stock.noler.com/us/stock/durata-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/durata-therapeutics-inc/income-taxes-receivable https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/durata-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/durata-therapeutics-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/durata-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/durata-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/durata-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/durata-therapeutics-inc/interest-expense-long-term-debt https://stock.noler.com/us/stock/durata-therapeutics-inc/interest-expense-other https://stock.noler.com/us/stock/durata-therapeutics-inc/interest-income-expense-net https://stock.noler.com/us/stock/durata-therapeutics-inc/interest-income-other https://stock.noler.com/us/stock/durata-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/durata-therapeutics-inc/inventory https://stock.noler.com/us/stock/durata-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/durata-therapeutics-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/durata-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/durata-therapeutics-inc/loan-processing-fee https://stock.noler.com/us/stock/durata-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/durata-therapeutics-inc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/durata-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/durata-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/durata-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/durata-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/durata-therapeutics-inc/net-income https://stock.noler.com/us/stock/durata-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-income https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/durata-therapeutics-inc/operating-leases-future-minimum-payments-receivable-current https://stock.noler.com/us/stock/durata-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/durata-therapeutics-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/other-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/durata-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/durata-therapeutics-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/durata-therapeutics-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/durata-therapeutics-inc/other-receivables https://stock.noler.com/us/stock/durata-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/durata-therapeutics-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/durata-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-of-financing-costs https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/durata-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/durata-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/durata-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/durata-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/durata-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/durata-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/durata-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/durata-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/durata-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/durata-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-license-fees-received https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/durata-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/durata-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/durata-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/durata-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/durata-therapeutics-inc/public-float https://stock.noler.com/us/stock/durata-therapeutics-inc/purchase-obligation https://stock.noler.com/us/stock/durata-therapeutics-inc/purchase-obligation-due-in-third-year https://stock.noler.com/us/stock/durata-therapeutics-inc/related-receivable-carrying-value-change https://stock.noler.com/us/stock/durata-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/durata-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/durata-therapeutics-inc/restricted-stock-expense https://stock.noler.com/us/stock/durata-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/durata-therapeutics-inc/revenue https://stock.noler.com/us/stock/durata-therapeutics-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/durata-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/durata-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/durata-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/durata-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/durata-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/durata-therapeutics-inc/share-price https://stock.noler.com/us/stock/durata-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/durata-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/durata-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/durata-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/durata-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/durata-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/durata-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/durata-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/durata-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/durata-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/durata-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/durata-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/durata-therapeutics-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/durata-therapeutics-inc/total-assets https://stock.noler.com/us/stock/durata-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/durata-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/durata-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/durata-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/durata-therapeutics-inc/utb-income-tax-penalties-accrued https://stock.noler.com/us/stock/durata-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/durata-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/durata-therapeutics-inc/valuation-allowance-amount https://stock.noler.com/us/stock/durata-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted